TF Capital (Shanghai)

TF Capital (Shanghai)

A venture capital firm in China that focuses on the life sciences industry and primarily investing in early stage companies.

TF Capital is a venture capital firm in China that focuses on the life sciences industry and primarily investing in early stage companies. Founded 2013 in Pudong, Shandong, China, it invests in series C, series B and series A rounds. Its portfolio companies include Alpha Biopharma, Eccogene, EOC Pharma Group, and GenFleet Therapeutics. As of April 2020, TF Capital has made 18 investments. Their most recent investment was on December 2, 2019, when EOC Pharma Group raised CN¥500M. EOC Pharma is an integrated biopharmaceutical company. TF Capital has had one exit, which was ZAI Lab. Zai Lab is a biopharmaceutical company based in Shanghai focused on bringing medicines for cancer, autoimmune and infectious diseases to patients in China and around the world.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Antengene

Antengene is a clinical-stage Asia-Pacific biopharmaceutical company focused on innovative oncology medicines.

2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Alpha Biopharma

Eccogene

EOC Pharma Group

GenFleet Therapeutics

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.